ENTX
NASDAQ · Biotechnology
Entera Bio Ltd
$3.15
-0.07 (-2.17%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,283.2% upside
Low Target
$34.30
Average Target
$43.57
High Target
$49.66
Current Price
$3.15
Current
$3.15
$3.15
Target
$43.57
$43.57
$34.30
$43.57 avg
$49.66
Scenario Analysis
Bear Case
$34.30
988.9%
Low target
Base Case
$43.57
+1,283.2%
Avg target
Bull Case
$49.66
+1,476.5%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$4.20
-25.0% from high
52-Week Low
$0.91
+246.2% from low
Target vs 52W High
$43.57
+937.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |